-+ 0.00%
-+ 0.00%
-+ 0.00%

Redhill Biopharma FY 2024 EPS $(0.00) Down From $0.01 YoY, Sales $8.04M Up From $6.53M YoY

Benzinga·04/10/2025 11:52:45
Listen to the news
Redhill Biopharma (NASDAQ:RDHL) reported quarterly losses of $(0.02) per share. This is a 300 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $8.04 million in sales this quarter. This is a 23.17 percent increase over sales of $6.53 million the same period last year.